<i>In vitro</i> exploration of drug-induced thrombotic microangiopathies: clues of diverse endothelial activation pathways respective to interferon-β1a, ciclosporin A, and gemcitabine exposure. [PDF]
Front PharmacolCubilier E +6 more
europepmc +1 more source
Toward a Restrictive Use of Plasma Exchanges in Thrombotic Microangiopathies. [PDF]
J Am Soc NephrolFrimat M +3 more
europepmc +1 more source
Educational Case: Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies and Potential Role of the Spleen. [PDF]
Acad Pathol, 2021 Nichols MM, Crane GM.
europepmc +1 more source
The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]
Orphanet J Rare DisMerlen C +8 more
europepmc +1 more source
Pregnancy as a susceptible state for thrombotic microangiopathies. [PDF]
Front Med (Lausanne)Frimat M +4 more
europepmc +1 more source
The Interaction Between Coagulation and Complement Cascades in the Management of Thrombotic Microangiopathies Related to Postpartum Hemorrhage. [PDF]
Kidney Int RepOrsi M, Ossola MW, Cetin I, Ardissino G.
europepmc +1 more source
Thrombotic microangiopathy in two tiger snake envenomations
Thrombotic microangiopathies are a rare group of disorders with features such as microangiopathic haemolytic anaemia, thrombocytopenia and renal failure.
Geoffrey Isbister (21130406) +1 more
core
Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies. [PDF]
Clin J Am Soc Nephrol, 2019 Fakhouri F, Frémeaux-Bacchi V.
europepmc +1 more source